The lawsuit is the result of a sweeping investigation that dates back years. In the course of the investigation, which Visa ...

The original developers of insulin deemed it unethical to profit off the life-saving therapeutic, selling the patent to the University of Toronto for just $1 in 1923. For the last 25 years, PBMs ...

Caremark, Express Scripts, Optum and their GPOs created a rebate system that boosted PBM profits, FTC alleges.

Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

Reuters reported that the court did not address the merits of the case, only that a Texas judge was wrong to dismiss it in February. Meanwhile, the Federal Trade Commission has accused the three ...

The owner of one of the three largest pharmacy middlemen in the United States last week filed suit to quash an attempt by the ...